Takeda recalls Natpara but warns patients not to abruptly stop treatment

Takeda’s been looking for a buyer for Natpara to provide some debt relief, but it has just run into some complicating circumstances. It is having to recall the eye drug from the market, a move it says may be very challenging for patients.